← Leaderboards
Antonio Roy Webb
Vesseltek Biomedical, Llc
$704,234
Attributed
$2,112,701
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $363.7K · FY2009–20$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$2,112,701 · 2
By mechanism
R01$1,812,385 · 1
R43$300,316 · 1
Top collaborators
- Josephine Allen5 shared
- Joseph Brad Case5 shared
- Guillermo A Ameer1 shared
- Melina Rae Kibbe1 shared
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroPolymersEndothelial CellsInflammationMigrationPharmaceutical PreparationsElastomericElastomersCellsHyperplasiaKineticsMedical DevicePatient CareCoagulation ProcessAnimal ModelDevicesBlood CoagulationBlood FlowAdhesionsBlood VesselsCell ProliferationFamily SuidaeCitratesPrevent
Grant awards (6)
Nanocomposite drug eluting stents for inhibition of restenosis and thrombosis$361,226
R01 · FY2020 · HL
Nanocomposite drug eluting stents for inhibition of restenosis and thrombosis$361,882
R01 · FY2019 · HL · contact PI
Nanocomposite drug eluting stents for inhibition of restenosis and thrombosis$362,507
R01 · FY2018 · HL · contact PI
Nanocomposite drug eluting stents for inhibition of restenosis and thrombosis$363,102
R01 · FY2017 · HL · contact PI
Nanocomposite drug eluting stents for inhibition of restenosis and thrombosis$363,668
R01 · FY2016 · HL · contact PI
Controlled Release Vascular Grafts$300,316
R43 · FY2009 · HL · contact PI